Discounted Cash Flow
Thermo Fisher Scientific Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $18.3b | $2.0b | $2.7b | 11.1% | $5.12 |
| 2017 | $20.9b (14.5%) | $2.2b (10.1%) | $3.6b (31.5%) | 10.6% (-3.9%) | $5.64 (10.2%) |
| 2018 | $24.4b (16.4%) | $2.9b (32.0%) | $4.0b (12.6%) | 12.1% (13.4%) | $7.31 (29.6%) |
| 2019 | $25.5b (4.9%) | $3.7b (25.8%) | $4.4b (9.8%) | 14.5% (20.0%) | $9.24 (26.4%) |
| 2020 | $32.2b (26.1%) | $6.4b (72.5%) | $7.6b (73.1%) | 19.8% (36.7%) | $16.09 (74.1%) |
| 2021 | $39.2b (21.7%) | $7.7b (21.2%) | $8.5b (11.1%) | 19.7% (-0.4%) | $19.62 (21.9%) |
| 2022 | $44.9b (14.5%) | $7.0b (-10.0%) | $8.2b (-3.7%) | 15.5% (-21.5%) | $17.75 (-9.5%) |
| 2023 | $42.9b (-4.6%) | $6.0b (-13.7%) | $7.3b (-10.2%) | 14.0% (-9.6%) | $15.52 (-12.6%) |
| 2024 | $42.9b (0.1%) | $6.3b (5.7%) | $7.5b (2.4%) | 14.8% (5.6%) | $16.58 (6.8%) |
| 2025 | $44.6b (3.9%) | $6.7b (5.8%) | $6.8b (-9.9%) | 15.0% (1.8%) | $17.77 (7.2%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.